Promising is the stimulation of internal endogenous antioxidant systems in patients with CIN, in particular, the “heme–biliverdin–bilirubin” series involving the enzyme HO-1, which may be a potent method for combating CIN and needs further research. This evidence concerns the gene HMOX1 and cervical squamous intraepithelial neoplasia.